Skip to main content
GWGovwatch
OfficialsBillsCommitteesMoneyMisconductLearn
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Forecast

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live
  • About This Site
  • Privacy Policy

Data Sources

Congress.gov
Bills, members, votesGovInfo
Floor speeches, reports, bill textFederal Election Commission
Campaign financeVoteView
Ideology scores (DW-NOMINATE)GovTrack
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S4327Referred to Committee

A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

Share:
Introduced
2
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-04-16
Introduced
0
Cosponsors
S
ⓘ
Type

Sponsor

Tom Cotton
Tom Cotton
Republican · AR · Senator

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2026-04-16

Read the full bill text
Read Full TextCongress.gov